Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 158: | Line 158: | ||
"APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban", | "APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban", | ||
"MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk", | "MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk", | ||
"MIST2" : "Second MIST trial", | |||
"TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist", | "TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist", | ||
"DAPT" : "Dual Antiplatelet Therapy", | "DAPT" : "Dual Antiplatelet Therapy", |